ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Oxxon Therapeutics Limited

Oxxon Therapeutics Limited is a dormant company incorporated on 20 November 1998 with the registered office located in Oxford, Oxfordshire. Oxxon Therapeutics Limited was registered 26 years ago.
Status
Dormant
Dormant since 16 years ago
Company No
03671700
Private limited company
Age
26 years
Incorporated 20 November 1998
Size
Micro
Turnover is under £1M
Under 10 employees
Confirmation
Due Soon
Dated 18 November 2024 (11 months ago)
Next confirmation dated 18 November 2025
Due by 2 December 2025 (24 days remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Jan31 Dec 2024 (1 year)
Accounts type is Dormant
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Address
Windrush Court
Transport Way
Oxford
OX4 6LT
Same address for the past 10 years
Telephone
01865398100
Email
Available in Endole App
People
Officers
3
Shareholders
1
Controllers (PSC)
1
Director • British • Lives in UK • Born in Aug 1979
Director • French • Lives in Germany • Born in Sep 1962
Director • Finance Director • British • Lives in England • Born in May 1972
Oxford Biomedica Plc
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Oxford Biomedica (UK) Limited
Stuart Paynter and Dr Lucinda Claire Crabtree are mutual people.
Active
Oxford Biomedica Plc
Stuart Paynter and Dr Lucinda Claire Crabtree are mutual people.
Active
Invivusbio Limited
Stuart Paynter and Dr Lucinda Claire Crabtree are mutual people.
Active
Ceres Power Limited
Stuart Paynter is a mutual person.
Active
Ceres Power Holdings Plc
Stuart Paynter is a mutual person.
Active
Ceres Intellectual Property Company Limited
Stuart Paynter is a mutual person.
Active
Ceres Power Intermediate Holdings Limited
Stuart Paynter is a mutual person.
Active
RFC Power Limited
Stuart Paynter is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period 31 Dec31 Dec 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£14.59M
Same as previous period
Total Liabilities
£0
Same as previous period
Net Assets
£14.59M
Same as previous period
Debt Ratio (%)
0%
Same as previous period
Latest Activity
Dormant Accounts Submitted
1 Month Ago on 1 Oct 2025
Charge Satisfied
4 Months Ago on 12 Jun 2025
Confirmation Submitted
11 Months Ago on 19 Nov 2024
Dormant Accounts Submitted
1 Year 1 Month Ago on 16 Sep 2024
Dr. Lucinda Claire Crabtree Appointed
1 Year 2 Months Ago on 2 Sep 2024
Stuart Paynter Resigned
1 Year 2 Months Ago on 2 Sep 2024
Confirmation Submitted
1 Year 11 Months Ago on 28 Nov 2023
Dormant Accounts Submitted
2 Years 1 Month Ago on 23 Sep 2023
Dr Frank Mathias Appointed
2 Years 7 Months Ago on 27 Mar 2023
Confirmation Submitted
2 Years 11 Months Ago on 21 Nov 2022
Get Credit Report
Discover Oxxon Therapeutics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Accounts for a dormant company made up to 31 December 2024
Submitted on 1 Oct 2025
Satisfaction of charge 3 in full
Submitted on 12 Jun 2025
Confirmation statement made on 18 November 2024 with no updates
Submitted on 19 Nov 2024
Accounts for a dormant company made up to 31 December 2023
Submitted on 16 Sep 2024
Termination of appointment of Stuart Paynter as a director on 2 September 2024
Submitted on 3 Sep 2024
Appointment of Dr. Lucinda Claire Crabtree as a director on 2 September 2024
Submitted on 3 Sep 2024
Confirmation statement made on 18 November 2023 with no updates
Submitted on 28 Nov 2023
Accounts for a dormant company made up to 31 December 2022
Submitted on 23 Sep 2023
Appointment of Dr Frank Mathias as a director on 27 March 2023
Submitted on 29 Mar 2023
Change of details for Oxford Biomedica Plc as a person with significant control on 21 November 2022
Submitted on 21 Nov 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year